Literature DB >> 7758016

Medulloblastoma in pediatric age: a single-institution review of prognostic factors.

L Cervoni1, G Cantore.   

Abstract

We report a retrospective study of 35 cases of medulloblastoma in pediatric patients treated at our institution during an 18-year period. Ten of the patients were infants (age < 2 years) and 25 were children (age > 2 years). The main factors affecting prognosis were total removal of the tumor (P < 0.01) and tumor stage (P < 0.01). There were no differences between the survival rate of infants and children, infants had a worse prognosis in regard to quality of life than children.

Entities:  

Mesh:

Year:  1995        PMID: 7758016     DOI: 10.1007/BF00303809

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  29 in total

1.  Wilms' tumor: its behavior and prognosis.

Authors:  V P COLLINS
Journal:  J La State Med Soc       Date:  1955-12

2.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

3.  Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival.

Authors:  E M Chatty; K M Earle
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

4.  Radiation treatment for medulloblastoma. A 21-year review.

Authors:  M P Berry; R D Jenkin; C W Keen; B D Nair; W J Simpson
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

5.  Medulloblastoma: a critical approach to the management on the basis of 12 years of experience.

Authors:  M Colangelo; B Daniele; R Ruggiero; A Buonaguro; A Ambrosio
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

6.  Treatment of medulloblastoma in children: long-term results following surgery, radiotherapy and chemotherapy.

Authors:  C Mazza; A Pasqualin; R Da Pian; E Donati
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

7.  Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure.

Authors:  C L Silverman; J R Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

8.  The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981.

Authors:  H J Bloom; J Glees; J Bell; S E Ashley; C Gorman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

9.  Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management.

Authors:  G Kopelson; R M Linggood; G M Kleinman
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

10.  Infants with medulloblastoma: a single institution review of survival.

Authors:  R Geyer; M Levy; M S Berger; J Milstein; B Griffin; W A Bleyer
Journal:  Neurosurgery       Date:  1991-11       Impact factor: 4.654

View more
  9 in total

1.  Appraisal of the current staging system for residual medulloblastoma by volumetric analysis.

Authors:  Dimitris Kombogiorgas; Stephanie Puget; Nathalie Boddaert; Andrew Peet; Martin English; Kal Natarajan; Jacques Grill; Dominique Couanet; Christian Sainte-Rose; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2011-08-04       Impact factor: 1.475

2.  Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.

Authors:  Kuan-Hsuan Chen; Chuan-Chih Hsu; Wen-Shin Song; Chi-Shuan Huang; Chia-Chen Tsai; Cheng-Deng Kuo; Han-Shui Hsu; Tung-Hu Tsai; Ching-Yao Tsai; Lin-Chung Woung; Shih-Hwa Chiou; Kai-Hsi Lu; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2010-06-05       Impact factor: 1.475

3.  Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity.

Authors:  Cheng-Chia Yu; Guang-Yuh Chiou; Yi-Yen Lee; Yuh-Lih Chang; Pin-I Huang; Yi-Wei Cheng; Lung-Kuo Tai; Hung-Hai Ku; Shih-Hwa Chiou; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2010-02-24       Impact factor: 1.475

4.  Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin?

Authors:  Roberta Salaroli; Tiziano Di Tomaso; Alice Ronchi; Claudio Ceccarelli; Silvia Cammelli; Alessandra Cappellini; Giuseppe Nicola Martinelli; Enza Barbieri; Felice Giangaspero; Giovanna Cenacchi
Journal:  J Neurooncol       Date:  2008-08-08       Impact factor: 4.130

5.  Caffeic acid phenethyl ester preferentially enhanced radiosensitizing and increased oxidative stress in medulloblastoma cell line.

Authors:  Yi-Yen Lee; Chung-Lan Kao; Ping-Hsing Tsai; Tung-Hu Tsai; Shih-Hwa Chiou; Wei-Fong Wu; Hung-Hai Ku; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2008-05-10       Impact factor: 1.475

6.  Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells.

Authors:  Kai-Hsi Lu; Yi-Wei Chen; Ping-Hsing Tsai; Ming-Long Tsai; Yi-Yen Lee; Chih-Yao Chiang; Chung-Lan Kao; Shih-Hwa Chiou; Hung-Hai Ku; Chi-Hung Lin; Yann-Jang Chen
Journal:  Childs Nerv Syst       Date:  2009-02-19       Impact factor: 1.475

7.  The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system.

Authors:  A S Y W Burns; E Jaros; M Cole; R Perry; A J Pearson; J Lunec
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

8.  In vitro stemness characterization of radio-resistant clones isolated from a medulloblastoma cell line ONS-76.

Authors:  Lue Sun; Takashi Moritake; Yun-Wen Zheng; Kenshi Suzuki; Ariungerel Gerelchuluun; Zhengshan Hong; Junko Zenkoh; Hideki Taniguchi; Koji Tsuboi
Journal:  J Radiat Res       Date:  2012-09-05       Impact factor: 2.724

9.  Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.

Authors:  Meng-Yin Yang; Hsu-Tung Lee; Chien-Min Chen; Chiung-Chyi Shen; Hsin-I Ma
Journal:  Int J Mol Sci       Date:  2014-06-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.